BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28166256)

  • 1. High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination.
    Qu F; Weschler LB; Sun Y; Sundell J
    PLoS One; 2017; 12(2):e0171438. PubMed ID: 28166256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15.
    Wahl B; O'Brien KL; Greenbaum A; Majumder A; Liu L; Chu Y; Lukšić I; Nair H; McAllister DA; Campbell H; Rudan I; Black R; Knoll MD
    Lancet Glob Health; 2018 Jul; 6(7):e744-e757. PubMed ID: 29903376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions.
    Levine OS; Knoll MD; Jones A; Walker DG; Risko N; Gilani Z
    Curr Opin Infect Dis; 2010 Jun; 23(3):236-41. PubMed ID: 20407316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance.
    ; Mackenzie GA; Hill PC; Jeffries DJ; Ndiaye M; Sahito SM; Hossain I; Uchendu U; Ameh D; Adeyemi O; Pathirana J; Olatunji Y; Abatan B; Muhammad BS; Ahameefula E; Fombah AE; Adeshola B; Lobga BG; Saha D; Mackenzie R; Odutola A; Plumb ID; Akano A; Ebruke BE; Ideh RC; Kuti B; Githua P; Olutunde E; Ofordile O; Green E; Usuf E; Badji H; Ikumapayi UN; Manjang A; Salaudeen R; Nsekpong ED; Jarju S; Antonio M; Sambou S; Ceesay L; Lowe-Jallow Y; Fofana S; Jasseh M; Mulholland K; Knoll M; Levine OS; Howie SR; Adegbola RA; Greenwood BM; Corrah T
    Lancet Infect Dis; 2021 Sep; 21(9):1293-1302. PubMed ID: 34280357
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Slack M; Esposito S; Haas H; Mihalyi A; Nissen M; Mukherjee P; Harrington L
    Expert Rev Vaccines; 2020 Oct; 19(10):903-917. PubMed ID: 32962476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of the Haemophilus influenzae type b vaccine for infants in mainland China.
    Ning G; Yin Z; Li Y; Wang H; Yang W
    Hum Vaccin Immunother; 2018 Jan; 14(1):36-44. PubMed ID: 29049002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review.
    Davis S; Feikin D; Johnson HL
    BMC Public Health; 2013; 13 Suppl 3(Suppl 3):S21. PubMed ID: 24564188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumonia hospitalizations of children aged <2 years in Poland before (2013-2016) and after (2017-2018) universal mass vaccination with 10-valent pneumococcal non-typeable
    Bhavsar A; Zaryczański J; Wasilewska A; Saragoussi D; Devadiga R; Colby C; Bahar E; Wysocki J
    Hum Vaccin Immunother; 2022 Nov; 18(6):2128566. PubMed ID: 36239615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
    Suga S; Ishiwada N; Sasaki Y; Akeda H; Nishi J; Okada K; Fujieda M; Oda M; Asada K; Nakano T; Saitoh A; Hosoya M; Togashi T; Matsuoka M; Kimura K; Shibayama K
    Vaccine; 2018 Sep; 36(38):5678-5684. PubMed ID: 30122645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptococcus pneumoniae and Haemophilus influenzae type b carriage in Chinese children aged 12-18 months in Shanghai, China: a cross-sectional study.
    Hu J; Sun X; Huang Z; Wagner AL; Carlson B; Yang J; Tang S; Li Y; Boulton ML; Yuan Z
    BMC Infect Dis; 2016 Apr; 16():149. PubMed ID: 27080523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
    Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
    Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumonia prevention: Cost-effectiveness analyses of two vaccines among refugee children aged under two years, Haemophilus influenzae type b-containing and pneumococcal conjugate vaccines, during a humanitarian emergency, Yida camp, South Sudan.
    Gargano LM; Hajjeh R; Cookson ST
    Vaccine; 2017 Jan; 35(3):435-442. PubMed ID: 27989625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia.
    Gargano LM; Hajjeh R; Cookson ST
    Prehosp Disaster Med; 2015 Aug; 30(4):402-11. PubMed ID: 26061190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting.
    Johnstone SL; Moore DP; Klugman KP; Madhi SA; Groome MJ
    Paediatr Int Child Health; 2020 Feb; 40(1):50-57. PubMed ID: 31156062
    [No Abstract]   [Full Text] [Related]  

  • 15. Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.
    Tsaban G; Ben-Shimol S
    Vaccine; 2017 May; 35(22):2882-2891. PubMed ID: 28449971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugate Haemophilus influenzae type b vaccines for sickle cell disease.
    Allali S; Chalumeau M; Launay O; Ballas SK; de Montalembert M
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD011199. PubMed ID: 30125338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries: A Systematic Review.
    Bonner K; Welch E; Elder K; Cohn J
    PLoS One; 2015; 10(8):e0135270. PubMed ID: 26332848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
    Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
    Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.
    Wijmenga-Monsuur AJ; van Westen E; Knol MJ; Jongerius RM; Zancolli M; Goldblatt D; van Gageldonk PG; Tcherniaeva I; Berbers GA; Rots NY
    PLoS One; 2015; 10(12):e0144739. PubMed ID: 26658902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.